Tax Exempt Hospital Transparency Act
Summary
HR9504, the Tax Exempt Hospital Transparency Act, has been introduced in the House and referred to the Ways and Means Committee. This is an early-stage bill with no cosponsor details or committee markup actions. Its specific transparency requirements are not detailed in the provided data, so the near-term financial impact on the hospital sector or any publicly traded company is negligible.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9504 is an early-stage bill with no text available; market impact is currently unmeasurable.
- 2.The bill uses a tax mechanism (threatened loss of tax-exempt status) to enforce transparency for nonprofit hospitals.
- 3.For-profit hospital chains ($HCA, $THC, $UHS) are structurally less exposed to this type of legislation than nonprofit systems.
Market Implications
No near-term market implications. The bill has only been introduced and referred to committee. Investors in for-profit hospital operators ($HCA, $THC, $UHS) can note they are structurally insulated from tax-exempt status changes, but this is a procedural observation, not a trading signal. Long-term, if the bill advances, it could marginally increase compliance costs for nonprofit competitors, slightly benefiting for-profit operators, but that is speculative at this point.
Full Analysis
- What happened and status: On 2026-06-29, Rep. Murphy (R-NC-3) introduced HR9504, the Tax Exempt Hospital Transparency Act. The bill has been referred to the House Committee on Ways and Means, the committee with jurisdiction over tax policy. This is a very early legislative stage — the bill has not been marked up, amended, or reported.
- The money trail: The bill title suggests it would impose conditions on the tax-exempt status of nonprofit hospitals, requiring additional transparency. No funding amount is specified — this is a regulatory bill, not an appropriation or authorization of spending. The mechanism would be a tax penalty (loss of tax-exempt status) for noncompliance, not direct government payments.
- Convergence: No convergence data was provided in the input, so no related signals, procurements, or presidential actions are analyzed here. The bill stands alone in the available context.
- Structural winners and losers: Without specific bill text, it is impossible to identify precise winners and losers. Generally, tax-exempt hospital transparency requirements increase compliance costs for nonprofit hospitals and may reduce the tax-exemption benefit, making them marginally less profitable. For-profit hospital operators ($HCA, $THC, $UHS) are not directly affected as they do not rely on tax-exempt status. Nonprofit health systems (privately held) bear the direct burden. No publicly traded company has a clear, near-term financial stake based on the provided data.
- Timeline: The bill is in the earliest legislative stage. It requires committee hearings, markup, and passage by the House (and likely Senate) to become law. The 119th Congress runs through January 2027, but with only about six months left, this bill is unlikely to advance significantly unless it gains bipartisan cosponsors and committee scheduling.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →